Subjects -> MEDICAL SCIENCES (Total: 8642 journals)
    - ALLERGOLOGY AND IMMUNOLOGY (218 journals)
    - ANAESTHESIOLOGY (120 journals)
    - CARDIOVASCULAR DISEASES (338 journals)
    - CHIROPRACTIC, HOMEOPATHY, OSTEOPATHY (21 journals)
    - COMMUNICABLE DISEASES, EPIDEMIOLOGY (234 journals)
    - DENTISTRY (293 journals)
    - DERMATOLOGY AND VENEREOLOGY (164 journals)
    - EMERGENCY AND INTENSIVE CRITICAL CARE (121 journals)
    - ENDOCRINOLOGY (150 journals)
    - FORENSIC SCIENCES (42 journals)
    - GASTROENTEROLOGY AND HEPATOLOGY (188 journals)
    - GERONTOLOGY AND GERIATRICS (138 journals)
    - HEMATOLOGY (157 journals)
    - HYPNOSIS (4 journals)
    - INTERNAL MEDICINE (174 journals)
    - LABORATORY AND EXPERIMENTAL MEDICINE (99 journals)
    - MEDICAL GENETICS (58 journals)
    - MEDICAL SCIENCES (2392 journals)
    - NURSES AND NURSING (364 journals)
    - OBSTETRICS AND GYNECOLOGY (207 journals)
    - ONCOLOGY (384 journals)
    - OPHTHALMOLOGY AND OPTOMETRY (140 journals)
    - ORTHOPEDICS AND TRAUMATOLOGY (170 journals)
    - OTORHINOLARYNGOLOGY (83 journals)
    - PATHOLOGY (100 journals)
    - PEDIATRICS (275 journals)
    - PHYSICAL MEDICINE AND REHABILITATION (158 journals)
    - PSYCHIATRY AND NEUROLOGY (833 journals)
    - RADIOLOGY AND NUCLEAR MEDICINE (192 journals)
    - RESPIRATORY DISEASES (104 journals)
    - RHEUMATOLOGY (79 journals)
    - SPORTS MEDICINE (81 journals)
    - SURGERY (406 journals)
    - UROLOGY, NEPHROLOGY AND ANDROLOGY (155 journals)

CARDIOVASCULAR DISEASES (338 journals)                  1 2 | Last

Showing 1 - 200 of 338 Journals sorted alphabetically
Acta Angiologica     Open Access   (Followers: 5)
Acta Cardiologica     Hybrid Journal   (Followers: 2)
Acute Cardiac Care     Hybrid Journal   (Followers: 8)
Adipositas - Ursachen, Folgeerkrankungen, Therapie     Hybrid Journal  
AJP Heart and Circulatory Physiology     Hybrid Journal   (Followers: 12)
Aktuelle Kardiologie     Hybrid Journal   (Followers: 1)
American Heart Journal     Hybrid Journal   (Followers: 60)
American Journal of Cardiology     Hybrid Journal   (Followers: 68)
American Journal of Cardiovascular Drugs     Hybrid Journal   (Followers: 17)
American Journal of Hypertension     Hybrid Journal   (Followers: 28)
Anales de Cirugia Vascular     Full-text available via subscription   (Followers: 1)
Anatolian Journal of Cardiology     Open Access   (Followers: 6)
Angiología     Full-text available via subscription  
Angiologia e Cirurgia Vascular     Open Access   (Followers: 1)
Angiology     Hybrid Journal   (Followers: 3)
Annales de Cardiologie et d'Angéiologie     Full-text available via subscription   (Followers: 1)
Annals of Circulation     Open Access   (Followers: 2)
Annals of Noninvasive Electrocardiology     Hybrid Journal   (Followers: 1)
Annals of Pediatric Cardiology     Open Access   (Followers: 12)
AORTA     Open Access  
Archives of Cardiovascular Diseases     Full-text available via subscription   (Followers: 5)
Archives of Cardiovascular Diseases Supplements     Full-text available via subscription   (Followers: 3)
Archives of Cardiovascular Imaging     Open Access   (Followers: 2)
Archivos de cardiología de México     Open Access   (Followers: 1)
Argentine Journal of Cardiology (English edition)     Open Access   (Followers: 2)
Arquivos Brasileiros de Cardiologia     Open Access   (Followers: 2)
Arrhythmia & Electrophysiology Review     Open Access   (Followers: 1)
Arteriosclerosis, Thrombosis and Vascular Biology     Full-text available via subscription   (Followers: 32)
Artery Research     Hybrid Journal   (Followers: 4)
ARYA Atherosclerosis     Open Access  
ASAIO Journal     Hybrid Journal   (Followers: 3)
ASEAN Heart Journal     Open Access   (Followers: 2)
Asian Cardiovascular and Thoracic Annals     Hybrid Journal   (Followers: 2)
Aswan Heart Centre Science & Practice Services     Open Access   (Followers: 1)
Atherosclerosis : X     Open Access  
Bangladesh Heart Journal     Open Access   (Followers: 3)
Basic Research in Cardiology     Hybrid Journal   (Followers: 10)
BMC Cardiovascular Disorders     Open Access   (Followers: 22)
Brain Circulation     Open Access   (Followers: 1)
British Journal of Cardiology     Full-text available via subscription   (Followers: 18)
Canadian Journal of Cardiology     Hybrid Journal   (Followers: 18)
Cardiac Cath Lab Director     Full-text available via subscription  
Cardiac Electrophysiology Review     Hybrid Journal   (Followers: 2)
Cardiac Failure Review     Open Access   (Followers: 1)
Cardiocore     Full-text available via subscription   (Followers: 1)
Cardiogenetics     Open Access   (Followers: 3)
Cardiology     Full-text available via subscription   (Followers: 20)
Cardiology and Angiology: An International Journal     Open Access   (Followers: 1)
Cardiology and Therapy     Open Access   (Followers: 12)
Cardiology Clinics     Full-text available via subscription   (Followers: 14)
Cardiology in Review     Hybrid Journal   (Followers: 8)
Cardiology in the Young     Hybrid Journal   (Followers: 34)
Cardiology Journal     Open Access   (Followers: 6)
Cardiology Plus     Open Access   (Followers: 1)
Cardiology Research     Open Access   (Followers: 15)
Cardiology Research and Practice     Open Access   (Followers: 10)
Cardiopulmonary Physical Therapy Journal     Hybrid Journal   (Followers: 8)
Cardiorenal Medicine     Full-text available via subscription   (Followers: 1)
Cardiothoracic Surgeon     Open Access   (Followers: 1)
CardioVasc     Full-text available via subscription   (Followers: 1)
Cardiovascular & Haematological Disorders - Drug Targets     Hybrid Journal   (Followers: 1)
Cardiovascular & Hematological Agents in Medicinal Chemistry     Hybrid Journal   (Followers: 2)
CardioVascular and Interventional Radiology     Hybrid Journal   (Followers: 15)
Cardiovascular and Thoracic Open     Open Access  
Cardiovascular Diabetology     Open Access   (Followers: 10)
Cardiovascular Drugs and Therapy     Hybrid Journal   (Followers: 14)
Cardiovascular Endocrinology & Metabolism     Hybrid Journal   (Followers: 1)
Cardiovascular Engineering     Hybrid Journal   (Followers: 1)
Cardiovascular Engineering and Technology     Hybrid Journal   (Followers: 1)
Cardiovascular Intervention and Therapeutics     Hybrid Journal   (Followers: 5)
Cardiovascular Journal     Open Access   (Followers: 6)
Cardiovascular Journal of Africa     Full-text available via subscription   (Followers: 5)
Cardiovascular Journal of South Africa     Full-text available via subscription   (Followers: 1)
Cardiovascular Medicine in General Practice     Full-text available via subscription   (Followers: 7)
Cardiovascular Pathology     Hybrid Journal   (Followers: 4)
Cardiovascular Regenerative Medicine     Open Access  
Cardiovascular Research     Hybrid Journal   (Followers: 15)
Cardiovascular Revascularization Medicine     Hybrid Journal   (Followers: 1)
Cardiovascular System     Open Access  
Cardiovascular Therapeutics     Open Access   (Followers: 1)
Cardiovascular Toxicology     Hybrid Journal   (Followers: 6)
Cardiovascular Ultrasound     Open Access   (Followers: 5)
Case Reports in Cardiology     Open Access   (Followers: 7)
Catheterization and Cardiovascular Interventions     Hybrid Journal   (Followers: 3)
Cerebrovascular Diseases     Full-text available via subscription   (Followers: 3)
Cerebrovascular Diseases Extra     Open Access  
Chest     Full-text available via subscription   (Followers: 103)
Choroby Serca i Naczyń     Open Access   (Followers: 1)
Circulation     Hybrid Journal   (Followers: 265)
Circulation : Cardiovascular Imaging     Hybrid Journal   (Followers: 15)
Circulation : Cardiovascular Interventions     Hybrid Journal   (Followers: 19)
Circulation : Cardiovascular Quality and Outcomes     Hybrid Journal   (Followers: 11)
Circulation : Genomic and Precision Medicine     Hybrid Journal   (Followers: 16)
Circulation : Heart Failure     Hybrid Journal   (Followers: 26)
Circulation Research     Hybrid Journal   (Followers: 36)
Cirugía Cardiovascular     Open Access  
Clínica e Investigación en Arteriosclerosis     Full-text available via subscription  
Clínica e Investigación en arteriosclerosis (English Edition)     Hybrid Journal  
Clinical and Experimental Hypertension     Hybrid Journal   (Followers: 3)
Clinical Cardiology     Hybrid Journal   (Followers: 11)
Clinical Hypertension     Open Access   (Followers: 5)
Clinical Medicine Insights : Cardiology     Open Access   (Followers: 6)
Clinical Research in Cardiology     Hybrid Journal   (Followers: 6)
Clinical Research in Cardiology Supplements     Hybrid Journal  
Clinical Trials and Regulatory Science in Cardiology     Open Access   (Followers: 4)
Congenital Heart Disease     Hybrid Journal   (Followers: 6)
Congestive Heart Failure     Hybrid Journal   (Followers: 4)
Cor et Vasa     Full-text available via subscription   (Followers: 1)
Coronary Artery Disease     Hybrid Journal   (Followers: 2)
CorSalud     Open Access  
Critical Pathways in Cardiology     Hybrid Journal   (Followers: 4)
Current Cardiology Reports     Hybrid Journal   (Followers: 7)
Current Cardiology Reviews     Hybrid Journal   (Followers: 4)
Current Cardiovascular Imaging Reports     Hybrid Journal   (Followers: 1)
Current Cardiovascular Risk Reports     Hybrid Journal  
Current Heart Failure Reports     Hybrid Journal   (Followers: 5)
Current Hypertension Reports     Hybrid Journal   (Followers: 6)
Current Hypertension Reviews     Hybrid Journal   (Followers: 6)
Current Opinion in Cardiology     Hybrid Journal   (Followers: 14)
Current Problems in Cardiology     Hybrid Journal   (Followers: 3)
Current Research : Cardiology     Full-text available via subscription   (Followers: 1)
Current Treatment Options in Cardiovascular Medicine     Hybrid Journal   (Followers: 1)
Current Vascular Pharmacology     Hybrid Journal   (Followers: 5)
CVIR Endovascular     Open Access   (Followers: 1)
Der Kardiologe     Hybrid Journal   (Followers: 2)
Echo Research and Practice     Open Access   (Followers: 2)
Echocardiography     Hybrid Journal   (Followers: 4)
Egyptian Heart Journal     Open Access   (Followers: 2)
Egyptian Journal of Cardiothoracic Anesthesia     Open Access  
ESC Heart Failure     Open Access   (Followers: 4)
European Cardiology Review     Open Access   (Followers: 1)
European Heart Journal     Hybrid Journal   (Followers: 68)
European Heart Journal - Cardiovascular Imaging     Hybrid Journal   (Followers: 10)
European Heart Journal - Cardiovascular Pharmacotherapy     Full-text available via subscription   (Followers: 2)
European Heart Journal - Quality of Care and Clinical Outcomes     Hybrid Journal  
European Heart Journal : Acute Cardiovascular Care     Hybrid Journal   (Followers: 1)
European Heart Journal : Case Reports     Open Access   (Followers: 1)
European Heart Journal Supplements     Hybrid Journal   (Followers: 8)
European Journal of Cardio-Thoracic Surgery     Hybrid Journal   (Followers: 9)
European Journal of Cardio-Thoracic Surgery Supplements     Full-text available via subscription   (Followers: 2)
European Journal of Cardiovascular Nursing     Hybrid Journal   (Followers: 5)
European Journal of Heart Failure     Hybrid Journal   (Followers: 14)
European Journal of Preventive Cardiology.     Hybrid Journal   (Followers: 6)
European Stroke Organisation     Hybrid Journal   (Followers: 3)
Experimental & Translational Stroke Medicine     Open Access   (Followers: 9)
Expert Review of Cardiovascular Therapy     Full-text available via subscription   (Followers: 3)
Folia Cardiologica     Open Access  
Forum Zaburzeń Metabolicznych     Hybrid Journal  
Frontiers in Cardiovascular Medicine     Open Access   (Followers: 1)
Future Cardiology     Hybrid Journal   (Followers: 6)
General Thoracic and Cardiovascular Surgery     Hybrid Journal   (Followers: 3)
Global Cardiology Science and Practice     Open Access   (Followers: 5)
Global Heart     Hybrid Journal   (Followers: 3)
Heart     Hybrid Journal   (Followers: 48)
Heart and Mind     Open Access  
Heart and Vessels     Hybrid Journal  
Heart Failure Clinics     Full-text available via subscription   (Followers: 2)
Heart Failure Reviews     Hybrid Journal   (Followers: 3)
Heart India     Open Access   (Followers: 2)
Heart International     Full-text available via subscription  
Heart Rhythm     Hybrid Journal   (Followers: 11)
Heart Views     Open Access   (Followers: 2)
HeartRhythm Case Reports     Open Access  
Hellenic Journal of Cardiology     Open Access   (Followers: 1)
Herz     Hybrid Journal   (Followers: 3)
High Blood Pressure & Cardiovascular Prevention     Full-text available via subscription   (Followers: 2)
Hypertension     Full-text available via subscription   (Followers: 23)
Hypertension     Open Access   (Followers: 2)
Hypertension in Pregnancy     Hybrid Journal   (Followers: 9)
Hypertension Research     Hybrid Journal   (Followers: 4)
Ibrahim Cardiac Medical Journal     Open Access  
IJC Heart & Vessels     Open Access   (Followers: 1)
IJC Heart & Vasculature     Open Access   (Followers: 1)
IJC Metabolic & Endocrine     Open Access   (Followers: 1)
Indian Heart Journal     Open Access   (Followers: 5)
Indian Journal of Cardiovascular Disease in Women WINCARS     Open Access  
Indian Journal of Thoracic and Cardiovascular Surgery     Hybrid Journal  
Indian Pacing and Electrophysiology Journal     Open Access   (Followers: 1)
Innovations : Technology and Techniques in Cardiothoracic and Vascular Surgery     Hybrid Journal   (Followers: 1)
Insuficiencia Cardíaca     Open Access  
Interactive CardioVascular and Thoracic Surgery     Hybrid Journal   (Followers: 7)
International Cardiovascular Forum Journal     Open Access  
International Journal of Angiology     Hybrid Journal   (Followers: 2)
International Journal of Cardiology     Hybrid Journal   (Followers: 18)
International Journal of Cardiology Hypertension     Open Access   (Followers: 1)
International Journal of Cardiovascular and Cerebrovascular Disease     Open Access   (Followers: 2)
International Journal of Cardiovascular Imaging     Hybrid Journal   (Followers: 2)
International Journal of Cardiovascular Research     Hybrid Journal   (Followers: 6)
International Journal of Heart Rhythm     Open Access  
International Journal of Hypertension     Open Access   (Followers: 8)
International Journal of Hyperthermia     Open Access  
International Journal of Stroke     Hybrid Journal   (Followers: 32)
International Journal of the Cardiovascular Academy     Open Access  
Interventional Cardiology Clinics     Full-text available via subscription   (Followers: 2)
Interventional Cardiology Review     Open Access  
JACC : Basic to Translational Science     Open Access   (Followers: 5)
JACC : Cardiovascular Imaging     Hybrid Journal   (Followers: 18)
JACC : Cardiovascular Interventions     Hybrid Journal   (Followers: 19)
JACC : Heart Failure     Full-text available via subscription   (Followers: 14)
JAMA Cardiology     Hybrid Journal   (Followers: 30)

        1 2 | Last

Similar Journals
Journal Cover
Argentine Journal of Cardiology (English edition)
Number of Followers: 2  

  This is an Open Access Journal Open Access journal
ISSN (Print) 0034-7000 - ISSN (Online) 2314-2286
Published by CAICYT- Centro Argentino de Información Científica y Tecnológica Homepage  [29 journals]
  • Cavernous Hemangioma of the Left Atrium

    • Authors: Ricardo Levin, Fernando Lipovetsky, Norma Nieva
      PubDate: 2020-05-28
      Issue No: Vol. 88 (2020)
       
  • Subcutaneous Implantable Cardioverter Defibrillator in a Patient with
           Pacemaker

    • Authors: David Doiny, Mauricio Abello, José Manuel Moltedo, Estela Falconi, Armando Pérez Silva, Carlos López
      PubDate: 2020-05-28
      Issue No: Vol. 88 (2020)
       
  • Influences in obesity

    • Authors: Juan Albarracín
      PubDate: 2020-05-28
      Issue No: Vol. 88 (2020)
       
  • Maternal Hemodynamics to Predict Hypertensive Disorders of Pregnancy:
           Should this be the Outlook'

    • Authors: Ana M. Escobar, Marcela C. Cabo Fustaret
      PubDate: 2020-05-28
      Issue No: Vol. 88 (2020)
       
  • Doctor´s as a machine, not as balance

    • Authors: María Elena Bastarrica
      PubDate: 2020-05-28
      Issue No: Vol. 88 (2020)
       
  • Clinical Cardiologist Viewpoint

    • Authors: Jorge Thierer
      PubDate: 2020-05-28
      Issue No: Vol. 88 (2020)
       
  • COULD THE INHIBITION OF MICRORNAS BE A TREATMENT OPTION FOR HEART FAILURE
           IN THE FUTURE'

    • Authors: Bruno Buchholz
      PubDate: 2020-05-28
      Issue No: Vol. 88 (2020)
       
  • The SAC in time of COVID

    • Authors: José Luis Navarro Estrada
      PubDate: 2020-05-28
      Issue No: Vol. 88 (2020)
       
  • Transcatheter aortic valve implantation. The prodigious decade

    • Authors: José-María Hernández-García, Antonio J. Muñoz-García
      PubDate: 2020-05-22
      Issue No: Vol. 88 (2020)
       
  • Multicenter Experience of Transcatheter Aortic Valve Implantation
           Stratified by Risk in Latin American Centers

    • Authors: Gerardo Nau, Ezequiel Zaidel, Marcelo Abud, Fernando Cura, Enrique Rivero, Emer Vitor, Dario Echeverri
      Abstract: Introduction: Transcatheter aortic valve implantation (TAVI) has been evaluated in different scenarios of the broad spectrumof patients with severe symptomatic aortic stenosis. The choice of treatment starts through a risk assessment guided by amultidisciplinary team.Purpose: The aim of this study was to analyze the population undergoing TAVI in Latin America according to their risk.Methods: From March 2009 to December 2018, consecutive TAVI procedures registered in the Latin American multicenter registrywere included. The indication of TAVI was made in each case by a multidisciplinary team set up by each center. The population isstratified according to the surgical risk evaluated by the STS-PROM score. Three groups were defined, based on the establishedSTS-PROM cut-off points: high risk (RA, higher 8%), intermediate risk (IR, between 4%-8%) and low risk (RB, lower 4%).Results: 770 patients were included in the analysis, resulting 50,2% female, with a mean age of 81 y/o (IQR 75.6-85.7). 29.8%were included in the AR group (STS-PROM 11 (9.3-16.7), 44% at intermediate risk (STS-PROM 6 (4.8-6.71) and 26.1% atlow risk (STS-PROM 2.7 (2-3.24). The proportion of low-risk patients has increased significantly over the period of inclusion(ptrend 0.011). Femoral access (95%), being percutaneous in 69% of patients. Self-expanding valves were implanted in 80%.23% of the valves were repositionable without differences across the groups. There was no differences in 30-day mortality(RA 10.4%, IR 6.48%, RB 5.9%, p 0.154). Reduction in mortality were observed (RA 13, 7-4.1%, p0.001; RB 11.7-0%; p 0.0023)during the analyzed period.Conclusions: Risk stratification through surgical “scores” continues to represent a very useful guide, however the indicationof TAVI in the real world incorporates other factors not contemplated in the classical score, which modifies our decisions indaily practice.
      PubDate: 2020-05-22
      Issue No: Vol. 88 (2020)
       
  • Argentine Registry of Acute Heart Failure (ARGEN-IC). Evaluation of a
           Partial Cohort at 30 Days

    • Authors: Adrián Lescano, Guillermina Soracio, Julieta Soricetti, Diego Arakaki, Lorena Coronel, Leonardo Cáceres, Hernán Cohen Arazi, Analía Benavidez, Alfredo Hirschson Prado, Alberto Fernández
      Abstract: Introduction: Acute Heart Failure is currently an epidemiological problem, with a close correlation with the increase in thepopulation age and the greater survival of patients with cardiovascular diseases.Objectives: Evaluate the clinical profile, the diagnostic and therapeutic strategies and the complications during hospitalizationand the 12-month follow up of the ARGEN IC Registry.Materials and Methods: It’s a prospective, multicenter, national Registry which included 50 health centers (August 2018-March 2019) and included patients with a confirmed diagnosis of acute heart failure with a 12-month follow-up.Results: A total of 909 patients were included, corresponding to 18 provinces and 73 active researchers. The mean age was 72.2(SD 14) years, 60.5% of the patients were males. Baseline characteristics include a prevalence of diabetes of 33%, previousAMI 17%, and Atrial Fibrillation 31% and a predominant private security medical coverage (38%) Among the trigger factorsof decompensation, 28.5% were associated with unknown causes, 15.7% infectious causes, and 13.5% with food transgression.The ischemic-necrotic etiology (26%), the presentation as mixed congestion (48%) and the impaired ejection fraction (EF)group stand out. 77.6% of the patients were admitted to the critical care unit, with a median overall hospital stay of 8 daysand overall mortality of 7.9%. The pharmacological treatment at discharge, including the group with reduced EF: Beta Blockers(BB) 78.7%, ACEI, ARA II or ARNI 70.9% and anti aldosteronic 56.3% and the referral to cardiovascular rehabilitationin 17%. The 30-day follow-up showed a rehopitalization rate of 16.7%, mortality of 5.5% and combined events of 18%. Only47% accessed the medical consultation.Conclusions: The ARGEN-IC Registry represents a heterogeneous population, with high middle ages and comorbidities. Thediagnostic and therapeutic strategies are underutilized during hospitalization and in the first 30 days, with poor access tothe health system. The overall combined rate of in-hospital events and at 30 days remains high.
      PubDate: 2020-05-22
      Issue No: Vol. 88 (2020)
       
  • Development of Subcutaneous Implants of Controlled Release Formulations of
           Carvedilol for Sustained Blood Pressure Reduction in Experimental Models
           of Hypertension

    • Authors: Miguel Allo, Camila Melody Boquete, Marcela Analía Morettón, Luciano Parola, Yanina SANTANDER PLANTAMURA, Facundo Martín Bertera, Diego Andrés Chiappetta, Christian HÖCHT
      Abstract: Objective: The aim of this study was the development and pharmacokinetic/pharmacodynamic evaluation of the in vivo releaseof subcutaneous implants of carvedilol capable of providing stable tissue levels in experimental models of hypertension.Methods: The subcutaneous implants were prepared with poly (epsilon-caprolactone) (PCL) and different proportions of theSoluPlus (SP) hydrophilic polymer (300:0; 250:50; 150:150 and 50:250 mg) loaded with 100 mg carvedilol. The plasma profileand the effect on systolic blood pressure (SBP) after subcutaneous implantation of each formulation was evaluated in malespontaneously hypertensive rats (SHR).Results: The PCL:SP 50:250 and 150:150 formulations provided levels ranging from 100 to 200 ng/mL and the PCL:SP 250:50and 300:0 formulations provided lower concentrations of carvedilol ranging from 0 to 100 ng/mL during the treatment period.Spontaneously hypertensive animals treated with the PCL:SP 50:250 y 150:150 implants presented a significant decrease inSBP (PCL:SP 50:250: DPAS: –36.6 ± 2.0 mm Hg; PCL:SP150:150: -35.7 ± 2.2 mmHg; p <0.05 vs. baseline values)Conclusions: The incorporation of the SoluPlus hydrophilic polymer in PC:SP 150:150 and 50:250 implants increases therelease of carvedilol, since it provides plasma concentrations ranging from 100 to 200 ng/ml, resulting in a sustained reductionof indirect SBP in SHR.
      PubDate: 2020-05-22
      Issue No: Vol. 88 (2020)
       
  • Survey on the Management of ST-Segment Elevation Myocardial Infarction in
           Hospitals from Rural Areas of Rio Negro, Argentina

    • Authors: Matías Enrique Calandrelli, Jorge Luis Bocian, María Emilia Saavedra, Juan Pablo Bonifacio, Daniel Abriata, Mariano Trevisan
      Abstract: Introduction: information on the management of AMI with a ST-segment elevation (IAMCEST) in rural areas of our countryis scarce.Objective: To know about the availability and use of diagnostic and therapeutic resources in the care of IAMCEST in ruralmedical centers in Río Negro provinceMethods: A structured, open-response, telephone survey was conducted, to on-call doctors from 8 hospitals of the South Line,all between 2 and 4 level (without intensive areas).Results: The IAMCEST patients are attended by generalists, who in half of the cases have no one to consult the ECG. Broadlythey do not have systematic systems or referral networks. Although 75% of the centers have more than 2 hours of derivation,most do not have streptokinase. Half of the referrals are cities that do not have hemodynamics for cases without coverage.Conclusion: The organization and availability of resources in IAMCEST care in rural areas of the province of Río Negro is scarce.
      PubDate: 2020-05-22
      Issue No: Vol. 88 (2020)
       
  • Low T3 Would Indicate Adverse Outcomes for Inpatients with Decompensated
           Heart Failure

    • Authors: Lucrecia Secco, Silvana Mettini, Cecilia Cejas, Cecilia Biglia, Dario A. Fernández, Stella M. Pereiro González
      Abstract: Background: Low T3 syndrome is associated with elevated circulating levels of cytokines and interleukins, reinforcing thehypothesis of a close relation between the neuroendocrine system and certain inflammatory and immunological mechanismsinvolved in heart failure.Objective: To assess the progress of patients admitted for decompensated heart failure according to T3 levels on admission,and events during hospitalization and follow-up.Materials and methods: It was a prospective, observational, analytical study of 524 patients hospitalized for the first timewith a diagnosis of decompensated heart failure. In-hospital and follow-up mortality and readmissions were evaluated accordingto normal or low T3 levels on admission. Ninety-one patients with known dysthyroidism, hypo or hyperthyroidism,previous thyroid surgery, sepsis or acute coronary syndrome were excluded. A subgroup analysis of patients receiving chronicamiodarone therapy was conducted, and prognostic variables were evaluated.Results: Of the 433 patients analyzed, 40.0% had low T3 (LT3) levels. Age, albumin level, age >75 years, and glomerularfiltration rate (GFR) were independent predictors of LT3. While adaptation of guideline-recommended treatments increasedin both groups, treatment rates in the LT3 group were significantly lower than those in the normal T3 (NT3) group (LT3vs. NT3: Betablockers 81.5% vs. 89.4%, p=0.02; ACEI/ARA II 78.5% vs. 87.9%, p=0.001; anti-aldosterone agents 29.2% vs.40.5%; p=0.019). Hospital mortality was higher in the LT3 group (5.8 vs. 1.5%), with no difference in rehospitalizations ormortality rates at follow-up. Of the subgroup of patients without amiodarone on admission (353), 37.8% had LT3. Patientsin this subgroup were found to have significant differences in follow-up and in-hospital mortality (5.3% in LT3 vs. 0.9% inNT3, p=0.03, and 40.2% vs. 26.6%, p=0.023) respectively.Conclusions: Decompensated heart failure patients with LT3 on admission would represent a subgroup with more severedisease and worse prognosis during hospitalization.
      PubDate: 2020-05-22
      Issue No: Vol. 88 (2020)
       
  • In Search of the Significant p. Its Influence on the Credibility of
           Publications

    • Authors: Jorge Thierer
      PubDate: 2020-05-22
      Issue No: Vol. 88 (2020)
       
  • Transesophageal Echocardiography in the Era of COVID-19. Use of the
           Aerosol Box as an Additional Barrier

    • Authors: María Celeste Carrero, Iván Iván Constantin; , Carla Pessio, Pablo G Stutzbach
      PubDate: 2020-04-27
      Issue No: Vol. 88 (2020)
       
  • Single-arm Meta-analysis of Argentine Studies Reporting 30-Day Mortality
           After Transcatheter Aortic Valve Implantation in Intermediate Risk
           Patients

    • Authors: Raul Borracci, Eugenia Amrein, Claudio C. Higa
      Abstract: Background: Transcatheter aortic valve implantation (TAVI) has been shown to be beneficial in patients with intermediaterisk; however, there is no overall analysis reporting TAVI results in our country.Objectives: To conduct a single-arm meta-analysis of local studies reporting 30-day outcomes after TAVI in intermediate riskpatients in Argentina.Methods: A systematic review on TAVI was performed using controlled trials and observational studies identified in MEDLINE,Embase, SCOPUS and Cochrane to August 2019.Results: Among 59 articles identified through the database search, only 4 local observational studies reported 30-day mortalityand complications after TAVI in moderate-risk patients according to the STS (Society of Thoracic Surgeons) score rangingbetween 4 and 7%. In 494 patients, 30-day mortality was 4.8%. Weighted pooled estimates of the studies were: stroke 2.7%,myocardial infarction 1.0%, need for a definitive pacemaker 24.8%, moderate or severe periprosthetic leakage 16.7%, andmajor bleeding 5.5%.Conclusions: The proven efficacy of TAVI is generating an expansion of its indication to patients with intermediate and lowrisk, However, this shift should be supported by local evidence of its benefit over traditional valve surgery. This single-armmeta-analysis of Argentine studies presents 30-day mortality and complications after TAVI in intermediate risk patients. Theupdated information of the local TAVI outcomes will serve as a standard in our settings.
      PubDate: 2020-04-01
      Issue No: Vol. 88 (2020)
       
  • Cardiopulmonary Exercise Testing: Reference Values in Adolescent and Adult
           Patients with Congenital Heart Diseases

    • Authors: Inés Abella, Alejandro C. Tocci, Claudio C. Morós, María Del C. Grippo
      Abstract: Background: The interpretation of cardiopulmonary exercise testing (CPET) in congenital heart diseases represents a challenge,since they constitute a large group of anomalies with different degrees of severity.Objectives: The aim of this study was to obtain reference values of CPET variables in adolescents and adults with congenitalheart diseases in our center, to compare between peers the expected results of CPET according to age, gender and the samepathology.Methods: A total of 799 tests were performed in 473 patients older than 17 years with different congenital heart diseases.Variables studied were peak VO2 (ml/kg/min), percent-predicted peak VO2, test duration in seconds (discriminated by gender),VE/VCO2 slope and R coefficient for all the tests. Statistical analyses were conducted using mean and standard deviation foreach variable and Student’s t test for those studied by gender.Results: Peak VO2 (ml/kg/min), percent-predicted peak VO2, and test duration decreased as the severity of heart diseasesincreased. The percent-predicted peak VO2 corrects VO2 ml/kg/min values for age and sex, so it becomes a more useful variablefor evaluation. An R coefficient greater than 1.1 indicates that patients performed a maximal test. The VE/VCO2 slopeis increased in severe heart diseases.Conclusions: Reference CPET values for the different congenital heart diseases are essential, since they allow us to comparepatients with the same pathology. The percent-predicted peak VO2 seems to be the most useful variable for this purpose.
      PubDate: 2020-03-19
      Issue No: Vol. 88 (2020)
       
  • Relationship Between Body Fat and Morbidity and Mortality in Cardiac
           Surgery

    • Authors: Diego Costa, Maximiliano Muzzio, Leonardo García Iturralde, Guillermina Esperón, Luciana Córsico, Enzo Catena, Carlos Luis Gonzalez, Vanesa Gregorietti, Luciano Saglietti, Roberto Coronel
      Abstract: Introduction: There is a potentially protective effect of obesity when it coexists with cardiovascular disease, known as the“obesity paradox.” It could be explained by the fact that anthropometric measurements are not a reliable marker of bodyfat. In this study we propose to estimate body fat with a non-invasive method and study its relationship with morbidity andmortality in cardiac surgery.Methods: We conducted a prospective and observational study in adult patients undergoing cardiac surgery. We analyzed demographic,anthropometric and clinical variables along with the estimation of body composition using bioelectric impedance,to study their association to hospitalization days and adverse events after cardiac surgery.Results: In the analysis of 98 patients, we found a direct relationship between the percentage of body fat and the length ofhospital stay, independent of age, sex, body mass index (BMI) and surgical risk (coefficient of 0.27, p = 0.021). In addition,patients who had mediastinitis showed a significantly higher body fat (31.55 ± 0.64% versus 27.13 ± 7.9%, p <0.001), andpatients who died had a tendency to have more fat mass (36.05 ± 3.19% versus 27.20 ± 7.82%, p = 0.08).Conclusion: Increased body fat as assessed with BIA was related to morbidity in cardiac surgery. Although this is biologicallyplausible, it would be necessary to carry out larger studies in order to definitively establish the “BMI paradox”.
      PubDate: 2020-03-19
      Issue No: Vol. 88 (2020)
       
  • Efficacy, Safety and Clinical Applicability of PCSK9 Inhibitors

    • Authors: Walter Masson, Mariano Giorgi
      Abstract: Proprotein convertase subtilisin kexin type 9 (iPCSK9) inhibitors represent a new group of lipid-lowering drugs that havegenerated a substantial change in lipid management. In a few years, a large number of studies have evaluated the lipid efficacyand safety of these drugs. More recently, large randomized clinical trials showed that the decrease in LDL-C achievedwith these drugs was associated with a lower incidence of cardiovascular events. Such evidence resulted in the approval andcommercialization of iPCSK9 in many countries. Consequently, various scientific societies and health reference agenciesincorporated these drugs into the therapeutic arsenal of dyslipidemia, with the aim of reducing residual cardiovascular risk.In this review, we will describe the efficacy and safety of these drugs, analyze the available evidence about cardiovascularbenefit, and discuss in which population their use might be most effective.
      PubDate: 2020-03-19
      Issue No: Vol. 88 (2020)
       
  • Hypothesis: Cough as a Complementary Maneuver to Avoid Vasovagal Syncope

    • Authors: G. Aurora Ruiz, Raul Chirife, Eliana Aversa, M. Cristina Tentori
      Abstract: Vasovagal syncope (VVS) is highly prevalent in thegeneral population. Although its prognosis is benign,in certain cases it implies an increased risk of trauma,as well as deterioration in quality of life. Thefirst line of treatment to avoid this condition consistsin informing and advising the patient on the indicatedhygienic-dietary measures. In the face of imminentsyncope with prodromes, physical maneuversthat rapidly increase blood pressure (BP) are implemented.
      PubDate: 2020-03-16
      Issue No: Vol. 88 (2020)
       
  • Percentage of Patients with Cardiac Electronic Devices Requiring Magnetic
           Resonance Imaging

    • Authors: Leandro Videla, Makarena Bibiloni, Sandy Posligua, Ricardo Venencia, Julieta Manattini, Alejandro Contreras
      PubDate: 2020-03-16
      Issue No: Vol. 88 (2020)
       
  • Cardiac Reintervention and Hemi-Commando Procedure in Double-Valve
           Endocarditis

    • Authors: Guillermo Gutierrez, Franco Gutiérrez, Renzo Melchiori, Gustavo Bastinelli, Guillermo Vaccarino
      PubDate: 2020-03-10
      Issue No: Vol. 88 (2020)
       
  • The Future of Cardiac Surgeons: Conversion of the Specialty

    • Authors: Raúl Borracci, Daniel O. Navia, Vadim Kotowicz
      PubDate: 2020-03-06
      Issue No: Vol. 88 (2020)
       
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
 


Your IP address: 3.230.154.129
 
Home (Search)
API
About JournalTOCs
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-